[go: up one dir, main page]

HK1046429A1 - 糖蛋白激素受體分子及其用途 - Google Patents

糖蛋白激素受體分子及其用途

Info

Publication number
HK1046429A1
HK1046429A1 HK02107632.7A HK02107632A HK1046429A1 HK 1046429 A1 HK1046429 A1 HK 1046429A1 HK 02107632 A HK02107632 A HK 02107632A HK 1046429 A1 HK1046429 A1 HK 1046429A1
Authority
HK
Hong Kong
Prior art keywords
hormone receptor
receptor molecules
glycoprotein hormone
molecules
stimulating hormone
Prior art date
Application number
HK02107632.7A
Other languages
English (en)
Inventor
Nikolics Karoly
C Mcfarlan Keith
L Segaloff Deborah
H Seeburg Peter
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of HK1046429A1 publication Critical patent/HK1046429A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2869—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against hormone receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A61P5/12—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C07K14/723—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Neurology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
HK02107632.7A 1989-05-05 2002-10-21 糖蛋白激素受體分子及其用途 HK1046429A1 (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US34768389A 1989-05-05 1989-05-05

Publications (1)

Publication Number Publication Date
HK1046429A1 true HK1046429A1 (zh) 2003-01-10

Family

ID=23364795

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02107632.7A HK1046429A1 (zh) 1989-05-05 2002-10-21 糖蛋白激素受體分子及其用途

Country Status (9)

Country Link
EP (3) EP0614975B1 (zh)
JP (1) JPH04505103A (zh)
AT (2) ATE115409T1 (zh)
AU (1) AU5732190A (zh)
DE (2) DE69015175T2 (zh)
DK (2) DK0471030T3 (zh)
ES (2) ES2068388T3 (zh)
HK (1) HK1046429A1 (zh)
WO (1) WO1990013643A2 (zh)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991003483A1 (en) * 1989-09-08 1991-03-21 New England Medical Center Hospitals, Inc. Tsh receptor
US5614363A (en) * 1990-01-25 1997-03-25 New England Medical Center Hospitals, Inc. TSH receptor
AU7257391A (en) * 1989-12-20 1991-07-18 Basil Rapoport Recombinant thyrotropin receptor
EP0475292B1 (en) * 1990-09-10 1999-06-30 Takeda Chemical Industries, Ltd. Human luteinizing hormone-human chorionic gonadotropin receptor (Human LH/hCG receptor)
ATE224446T1 (de) * 1991-03-15 2002-10-15 Applied Research Systems Menschlicher rezeptor für das follikel- stimulierendes hormon.
WO1993020199A1 (en) * 1992-03-30 1993-10-14 Akzo Nobel N.V. Human gonadotropin receptor (fsh receptor)
US6033903A (en) * 1995-06-02 2000-03-07 Applied Research Systems, ARS Holding N.V. Method of expressing and secreting soluble extracellular domains of human gonadotropin hormone receptors
EP0910648A1 (en) * 1996-04-15 1999-04-28 The Board Of Trustees Of The Leland Stanford Junior University Soluble 7-transmembrane domain g-protein-coupled receptor compositions and methods
US5858716A (en) 1997-05-30 1999-01-12 Smithkline Beecham Corporation H2CAA71 polynucleotides
EP1049779A2 (en) * 1998-01-20 2000-11-08 Wilex Biotechnology GmbH Lh-receptor gene promoter for tissue-specific gene expression
GB9909661D0 (en) 1998-06-06 1999-06-23 Rsr Ltd Assays for TSH receptor autoantibodies
ES2466377T3 (es) 2001-08-23 2014-06-10 Rsr Limited Regiones epitópicas de un receptor de tirotropina (TSH), usos de las mismas y anticuerpos para las mismas

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4560649A (en) * 1981-10-15 1985-12-24 Cornell Research Foundation Assaying for hLH or hCG with immobilized hormone receptors
US4761371A (en) * 1985-02-12 1988-08-02 Genentech, Inc. Insulin receptor
US4921808A (en) * 1986-06-25 1990-05-01 The Albany Medical College Of Union University Method for determining follicle stimulating hormone
WO1991003483A1 (en) * 1989-09-08 1991-03-21 New England Medical Center Hospitals, Inc. Tsh receptor
ATE145240T1 (de) * 1989-12-14 1996-11-15 Brahms Diagnostica Gmbh Polypeptide mit thyrotropinrezeptor-aktivität, kodierende nukleinsäuresequenzen für solche rezeptoren und verwendung dieser polypeptide
AU7257391A (en) * 1989-12-20 1991-07-18 Basil Rapoport Recombinant thyrotropin receptor
FR2657014A1 (fr) * 1990-01-15 1991-07-19 Inst Nat Sante Rech Med Recepteur humain de la tsh. sequence codant pour ce recepteur.

Also Published As

Publication number Publication date
DE69033990D1 (de) 2002-08-29
DE69033990T2 (de) 2003-02-13
WO1990013643A2 (en) 1990-11-15
ES2068388T3 (es) 1995-04-16
DK0614975T3 (da) 2002-11-11
EP1199361A3 (en) 2004-03-10
DK0471030T3 (da) 1995-05-29
EP0614975A1 (en) 1994-09-14
EP0471030B1 (en) 1994-12-14
EP0471030A1 (en) 1992-02-19
ES2180550T3 (es) 2003-02-16
ATE115409T1 (de) 1994-12-15
JPH04505103A (ja) 1992-09-10
DE69015175T2 (de) 1995-06-29
WO1990013643A3 (en) 1991-01-10
AU5732190A (en) 1990-11-29
DE69015175D1 (de) 1995-01-26
EP1199361A2 (en) 2002-04-24
EP0614975B1 (en) 2002-07-24
ATE221123T1 (de) 2002-08-15

Similar Documents

Publication Publication Date Title
EP0236684A3 (en) Galanthamine or analogues thereof for treating alzheimer's disease
BG100517A (en) Combination of bisphosphonates and growth hormone secretagogues
EP0671920A4 (en) AN ANTI-IDIOTYPICAL ANTIBODY AND ITS USE IN THE DIAGNOSIS AND THERAPY OF HIV-RELATED DISEASES.
IE940809L (en) Ultrasonic contrast agents, process for their preparation¹and their use as diagnostic and therapeutic agents
ZA946142B (en) Therapeutic heterocycles
HK1046429A1 (zh) 糖蛋白激素受體分子及其用途
DE69333885D1 (en) C-c ckr-1, ein c-c chemokin rezeptor
EP0959896A4 (en) COMPOSITIONS BASED ON THE HUMAN THYROTROPIN RECEPTOR AND THEIR USE
DK143492A (da) Human-h2-praeprorelaxin, -prorelaxin og -relaxin samt polypeptid med relaxinaktivitet
EP0786995A4 (zh)
EP0322226A3 (en) Site-directed mutagenesis modified glycoprotein hormones and methods of use
HUT59833A (en) Process for producing pharmaceutical compositions containing calcitoninogene like peptides for treating erectional disfunctions
EP0417003A3 (en) Use of antiprogestomimetics for stimulating ovulation
ZA878249B (en) Method and therapeutic compositions for the treatment of bleeding disorders
IL93034A0 (en) Recombinant human thyrotropin,its production and its use in diagnostics and treatment
DE3886517D1 (de) Menschlicher Prourokinase ähnliches Polypeptid.
IL88381A (en) Peptide structures, immunogens containing them and their uses in the control of fertility
EP0153961A4 (en) RECOMBINANT SUBSTANCES AND METHODS OF PRODUCING PEPTIDE III ACTIVATING HUMAN CONNECTIVE TISSUE AND THE LIKE.
NZ220242A (en) Regulating fertility in cattle by administering epostane
王殿洪 et al. PURIFICATION AND CHARACTERIZATION OF INSULIN RECEPTORS FROM HUMAN PLACENTA
CS495286A1 (en) Mouse lymhocytaric hybridom producing antibody against human choriogonadotropic hormone
HK1013296A1 (en) Analogs of thymosin alpha 1
HUT37030A (en) Therapeutic auxiliary device for the treatment of traumatological patients, first of all with lower limb fraction
BG45632A1 (en) Hybridome cell line, producing monoclonal antibodys against anticell determinant of zone pellucida from ovum of person, pig and mouse
ATE98990T1 (de) Menschlicher prourokinase aehnliches polypeptid.